Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jostein Starrfelt

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Trends in Ecology & Evolution|September 11, 2023
Measurement theory and paleobiologyKjetil Lysne Voje, James G Saulsbury, Jostein Starrfelt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 13, 2021
No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in NorwayLamprini Veneti, Beatriz Valcarcel Salamanca, Elina Seppälä, et al.
The Journal of Infectious Diseases|October 19, 2022
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian CohortIda Laake, Siri N Skodvin, Kristine Blix, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 29, 2022
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022Alexis Sentís, Irina Kislaya, Nathalie Nicolay, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 28, 2022
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022Lamprini Veneti, Håkon Bøås, Anja Bråthen Kristoffersen, et al.
BMJ (Clinical Research Ed.)|July 24, 2023
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analysesNiklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 7, 2023
A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022Tommy Nyberg, Peter Bager, Ingrid Bech Svalgaard, et al.
Bioscience|April 19, 2021
The Hierarchy-of-Hypotheses Approach: A Synthesis Method for Enhancing Theory Development in Ecology and EvolutionTina Heger, Carlos A Aguilar-Trigueros, Isabelle Bartram, et al.
Influenza and Other Respiratory Viruses|November 29, 2023
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022Irina Kislaya, Alexis Sentís, Jostein Starrfelt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 5, 2024
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023Mario Fontán-Vela, Esther Kissling, Nathalie Nicolay, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Trends in Ecology & Evolution|September 11, 2023
Measurement theory and paleobiologyKjetil Lysne Voje, James G Saulsbury, Jostein Starrfelt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 13, 2021
No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in NorwayLamprini Veneti, Beatriz Valcarcel Salamanca, Elina Seppälä, et al.
The Journal of Infectious Diseases|October 19, 2022
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian CohortIda Laake, Siri N Skodvin, Kristine Blix, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 29, 2022
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022Alexis Sentís, Irina Kislaya, Nathalie Nicolay, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 28, 2022
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022Lamprini Veneti, Håkon Bøås, Anja Bråthen Kristoffersen, et al.
BMJ (Clinical Research Ed.)|July 24, 2023
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analysesNiklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 7, 2023
A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022Tommy Nyberg, Peter Bager, Ingrid Bech Svalgaard, et al.
Bioscience|April 19, 2021
The Hierarchy-of-Hypotheses Approach: A Synthesis Method for Enhancing Theory Development in Ecology and EvolutionTina Heger, Carlos A Aguilar-Trigueros, Isabelle Bartram, et al.
Influenza and Other Respiratory Viruses|November 29, 2023
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022Irina Kislaya, Alexis Sentís, Jostein Starrfelt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 5, 2024
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023Mario Fontán-Vela, Esther Kissling, Nathalie Nicolay, et al.
Pageof 4